Hypoxia-Inducible Factor-1α (HIF-1α) is integral to the progression of ovarian cancer, facilitating angiogenesis, metabolic reprogramming, epithelial-to-mesenchymal transition, and resistance to therapy. Here, HIF1A is linked to ovarian cancer.